Name | Walgreens #4972 |
---|---|
Organization Name | Walgreen Co |
Location | 3937 Vogel Rd, Arnold, Missouri 63010 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (636) 282-7068 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The U.S. Food and Drug Administration today warned patients and health care providers about the possible risk of atypical thigh bone (femoral) fracture in patients who take bisphosphonates, a class of drugs used to prevent and treat osteoporosis. A labeling change and Medication Guide will reflect this risk. Bisphosphonates inhibit the loss of bone mass in people with osteoporosis.
Mylan Inc. today confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals and Mylan settling patent litigation in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for Frovatriptan Succinate Tablets, 2.5 mg.
According to a recent survey conducted by a charity Macmillan Cancer Support, when compared, getting cancer can be more expensive than having a baby. The survey finds that cancer costs a patient £570 per month not only in terms of direct treatment costs but also indirect costs including lost work days; travel to and from hospitals and clinics etc.
Jivan Biologics, Inc. announced today that the United States Patent and Trademark Office has ordered the re-examination of U.S. Patent No. 6,881,571. The serial number for the reexamination is 90/009,017.
› Verified 6 days ago
NPI Number | 1295742203 |
Organization Name | WALGREEN CO |
Doing Business As | WALGREENS #04972 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 3937 Vogel Rd, Arnold, MO 63010 |
Phone Number | 636-282-7068 |
News Archive
The U.S. Food and Drug Administration today warned patients and health care providers about the possible risk of atypical thigh bone (femoral) fracture in patients who take bisphosphonates, a class of drugs used to prevent and treat osteoporosis. A labeling change and Medication Guide will reflect this risk. Bisphosphonates inhibit the loss of bone mass in people with osteoporosis.
Mylan Inc. today confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals and Mylan settling patent litigation in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for Frovatriptan Succinate Tablets, 2.5 mg.
According to a recent survey conducted by a charity Macmillan Cancer Support, when compared, getting cancer can be more expensive than having a baby. The survey finds that cancer costs a patient £570 per month not only in terms of direct treatment costs but also indirect costs including lost work days; travel to and from hospitals and clinics etc.
Jivan Biologics, Inc. announced today that the United States Patent and Trademark Office has ordered the re-examination of U.S. Patent No. 6,881,571. The serial number for the reexamination is 90/009,017.
› Verified 6 days ago
News Archive
The U.S. Food and Drug Administration today warned patients and health care providers about the possible risk of atypical thigh bone (femoral) fracture in patients who take bisphosphonates, a class of drugs used to prevent and treat osteoporosis. A labeling change and Medication Guide will reflect this risk. Bisphosphonates inhibit the loss of bone mass in people with osteoporosis.
Mylan Inc. today confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals and Mylan settling patent litigation in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for Frovatriptan Succinate Tablets, 2.5 mg.
According to a recent survey conducted by a charity Macmillan Cancer Support, when compared, getting cancer can be more expensive than having a baby. The survey finds that cancer costs a patient £570 per month not only in terms of direct treatment costs but also indirect costs including lost work days; travel to and from hospitals and clinics etc.
Jivan Biologics, Inc. announced today that the United States Patent and Trademark Office has ordered the re-examination of U.S. Patent No. 6,881,571. The serial number for the reexamination is 90/009,017.
› Verified 6 days ago
Cvs Pharmacy #10071 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2120 Lone Star Dr, Arnold, Missouri 63010 Phone: (636) 287-1381 | |
Cvs Pharmacy #16623 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3849 Vogel Rd, Arnold, Missouri 63010 Phone: (636) 287-1339 | |
Cvs Pharmacy #18020 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3900 Vogel Rd, Arnold, Missouri 63010 Phone: (636) 282-7555 | |
Walgreens #4972 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3937 Vogel Rd, Arnold, Missouri 63010 Phone: (636) 282-7068 | |
Dierbergs Arnold Commons Pharmacy Type: Community/Retail Pharmacy Location: 860 Arnold Commons Dr, Arnold, Missouri 63010 Phone: (636) 282-4817 |